It is another unique feature of mutant KRAS that the G12C variant in lung cancer is the major oncogenic driver, while in other tumors, mutant KRAS (which is either G12D or G12V) is a minidriver cooperating with other driver oncogenes [7,23]. Here, KRAS is linked to lung cancer.